54
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Maintenance of improved lipid levels following attendance at a cardiovascular risk reduction clinic: a 10-year experience

, , , , , , , & show all
Pages 1127-1135 | Published online: 10 Oct 2008

References

  • AndersonKMCastelliWPLevyD1987Cholesterol and mortality: 30 years of follow up from the Framingham studyJAMA2572176803560398
  • BaigentCKeechAKearneyPM2005Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomized trials of statinsLancet36612677816214597
  • CastelliWPGarrisonRJWilsonPWF1986Incidence of coronary heart disease and lipoprotein cholesterol levelsJAMA256283583773200
  • CookeCEHammerashWJJr2006Retrospective review of sex differences in the management of dyslipidemia in coronary heart disease: an analysis of patient data from a Maryland-based health maintenance organizationClin Ther28591916750470
  • FodorJGFrolichJJGenestJJGJr2000Recommendations for the management and treatment of dyslipidemiaCMAJ1621441710834048
  • Garcia RuizFJMarin IbanezAPerez-JiminezF2004Current lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY StudyPharmacoeconomics22Suppl 311215669149
  • GavishDLeibovitzEEllyI2002Follow-up in a lipid clinic improves the management of risk factors in cardiovascular disease patientsIsr Med Assoc J4694712440233
  • GrundySMPasternakRGreenlandP1999Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of CardiologyCirculation10014819210500053
  • HarrisDEGipsonGWPearsonTA1998Lipid lowering in a multidisciplinary clinic compared with primary physician managementAm J Cardiol81929339555787
  • Heart and Stroke Foundation of Canada1999The changing face of heart disease and stroke in Canada 2000Laboratory Centre for Disease Control, Health Canada, Statistics Canada, Canadian Institute for Health Information, Canadian Cardiovascular Society, Canadian Stroke Society, Heart Stroke Foundation of CanadaOttawa
  • KorenMJHunninghakeDB2004Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinicsJ Am Coll Card4417729
  • MajumdarSRGurwitzJHSoumeraiSB1999Undertreatment of hyper-lipidemia in the secondary prevention of coronary artery diseaseJ Gen Intern Med14711710632815
  • McPhersonRFrohlichJFodorJ2006Canadian Cardiovascular Society position statement – recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular diseaseCan J Cardiol229132716971976
  • MurrayCJLopezAD1997Global mortality, disability, and the contribution of risk factors: Global Burden of Disease StudyLancet3491436429164317
  • [NCEP ATP III] National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)2002Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final reportCirculation106314342112485966
  • NeatonJDBlackburnHJacobsD1992Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial (MRFIT)Arch Intern Med15214905001627030
  • OlsonKLRasmussenJSandhoffBG2005Lipid management in patients with coronary artery disease by a clinical pharmacy service in a group model health maintenance organizationArch Intern Med165495415642874
  • PearsonTALauroraIChuH2000The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goalsArch Intern Med1604596710695686
  • SalantPDillmanD1994How to conduct your own surveyNew YorkJohn Wiley and Sons
  • SchrottHGBittnerVVittinghoffE1997Adherence to National Cholesterol Education Program treatment goals in postmenopausal women with heart disease. The Heart Estrogen/Progestin Replacement Study (HERS). The HERS Research GroupJAMA277128169109465
  • ShafferJWexlerLF1995Reducing low-density lipoprotein cholesterol levels in an ambulatory care systemArch Intern Med155233057487258
  • StacyTAEggerA2006Results of a retrospective chart review to determine improvement in lipid goal attainment in patients treated by high-volume prescribers of lipid-modifying drugsJ Manag Care Pharm127455117249907
  • StamlerJWentworthDNeatonJ1996Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT)JAMA256282373773199
  • TaherTHDzavikVReteffEM2002Tolerability of statin-fibrate and statin-niacin combination therapy in dyslipidemic patients at high risk for cardiovascular eventsAm J Cardiol89390411835917
  • WilsonTWQuestDWWilsonM1999A cardiovascular risk factor reduction clinicCan J Cardiol158879110446436
  • YatesSAnnisLPippinsJ2001Does a lipid clinic increase compliance with National Cholesterol Education Program treatment guidelines? Report of a case-matched control studySouth Med J94907911592752